scholarly journals Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease

2017 ◽  
Vol 13 (8) ◽  
pp. 933-939 ◽  
Author(s):  
David W. Fardo ◽  
Laura E. Gibbons ◽  
Shubhabrata Mukherjee ◽  
M. Maria Glymour ◽  
Wayne McCormick ◽  
...  
2016 ◽  
Vol 12 ◽  
pp. P643-P644
Author(s):  
David W. Fardo ◽  
Laura E. Gibbons ◽  
Shubhabrata Mukherjee ◽  
M. Maria Glymour ◽  
Wayne McCormick ◽  
...  

2018 ◽  
Vol 107 ◽  
pp. 148-160 ◽  
Author(s):  
Anatoliy I. Yashin ◽  
Fang Fang ◽  
Mikhail Kovtun ◽  
Deqing Wu ◽  
Matt Duan ◽  
...  

2006 ◽  
Vol 2 ◽  
pp. S23-S23
Author(s):  
Lars Bertram ◽  
Matthew B. McQueen ◽  
Kristina Mullin ◽  
Deborah Blacker ◽  
Rudolph E. Tanzi

2008 ◽  
Vol 168 (8) ◽  
pp. 855-865 ◽  
Author(s):  
Fotini K. Kavvoura ◽  
Matthew B. McQueen ◽  
Muin J. Khoury ◽  
Rudolph E. Tanzi ◽  
Lars Bertram ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Zhangyu Zou ◽  
Changyun Liu ◽  
Chunhui Che ◽  
Huapin Huang

Alzheimer’s disease (AD) is the most common progressive neurodegenerative disease and the most common form of dementia in the elderly. It is a complex disorder with environmental and genetic components. There are two major types of AD, early onset and the more common late onset. The genetics of early-onset AD are largely understood with mutations in three different genes leading to the disease. In contrast, while susceptibility loci and alleles associated with late-onset AD have been identified using genetic association studies, the genetics of late-onset Alzheimer’s disease are not fully understood. Here we review the known genetics of early- and late-onset AD, the clinical features of EOAD according to genotypes, and the clinical implications of the genetics of AD.


Sign in / Sign up

Export Citation Format

Share Document